CLINICAL_TRIALS
trial_result
· 2023-09-26
Clinical Trial Update: Enzalutamide With or Without Vaccine Therapy for Advanced Prostate Cancer [Phase 2]
Summary
Phase 2 clinical trial evaluating enzalutamide with or without vaccine therapy in advanced prostate cancer has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-09-26